Back to company

PHARMAORIGIN ApS: Financial statements 2012

CVR: 29178291

PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK -149,195. Equity amounted to DKK 805,720. The solvency ratio was 16.3%.

Profit/Loss
-149,195 kr.
Equity
805,720 kr.
Total Assets
4,943,772 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAORIGIN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

Lars Heslet leaves the board of PHARMAORIGIN ApSJun 21, 2012

As of June 21, 2012, Lars Heslet has left the board of directors of PHARMAORIGIN ApS.

Eric Jean Marie Leire leaves the board of PHARMAORIGIN ApSJun 21, 2012

As of June 21, 2012, Eric Jean Marie Leire has left the board of directors of PHARMAORIGIN ApS.

About PHARMAORIGIN ApS

PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.